Search company, investor...

Luminous Medical

luminousmedical.com

Founded Year

2005

Stage

Series B | Alive

Total Raised

$32.5M

Last Raised

$23.5M | 15 yrs ago

About Luminous Medical

Luminous Medical is developing a new device to allow the near continuous measurement of blood glucose and other analytes in the hospital environment.

Headquarters Location

1920 Palomar Point Way

Carlsbad, California, 92008,

United States

760-448-4814

Missing: Luminous Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Luminous Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Luminous Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Luminous Medical is included in 1 Expert Collection, including Diabetes.

D

Diabetes

1,903 items

Luminous Medical Frequently Asked Questions (FAQ)

  • When was Luminous Medical founded?

    Luminous Medical was founded in 2005.

  • Where is Luminous Medical's headquarters?

    Luminous Medical's headquarters is located at 1920 Palomar Point Way, Carlsbad.

  • What is Luminous Medical's latest funding round?

    Luminous Medical's latest funding round is Series B.

  • How much did Luminous Medical raise?

    Luminous Medical raised a total of $32.5M.

  • Who are the investors of Luminous Medical?

    Investors of Luminous Medical include De Novo Ventures, Latterell Venture Partners, RiverVest Venture Partners, Adams Street Partners, Finistere Ventures and 3 more.

  • Who are Luminous Medical's competitors?

    Competitors of Luminous Medical include Sotera Wireless, OptiScan Biomedical, GlySure, Apieron, Vytrace and 11 more.

Compare Luminous Medical to Competitors

A
ArKal Medical

Arkal Medical is developing a continuous blood glucose sensor for diabetes.

Bay Area Digital Logo
Bay Area Digital

Bay Area Digital is a company that received a SBIR Phase I grant for a project entitled: Talking Blood Glucose Meter with full Accessibility for Blind, Visually and Cognitively Impaired. Their Project addresses a crisis in the lack of effective glucose monitoring equipment for visually and cognitively impaired diabetics. The proposal thoroughly examines the technical and commercial feasibility of developing innovative technology that enables such patients to reliably use information provided by a state-of-the-art blood glucose meter, using speech output that is coupled with a commercially developed meter. There are currently no state-of-the-art or best-of-breed blood glucose meter systems available in the U.S. market with speech capabilities for use by the cognitively, visually impaired or blind community. The development of such a meter will positively impact the self-management of diabetes mellitus, improving quality of life and clinical outcomes for patients and preventing the development of secondary complications and provide an opportunity to impact a major health problem affecting millions of U.S. citizens.

V
Vytrace

Vytrace Corporation is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. Vytrace Corporation is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. This is not a consumer product for diabetic glucose monitoring. They also are exploring other analytes that may be monitored with their sensor technology. Vytrace Corporation has a highly accurate bedside monitor that automatically and continuously monitors blood glucose via a fiberoptic catheter with a photonic crystal sensor on the tip.

N
Novoculi

Located in Hanover, NH and San Francisco, CA, Novoculi is a medical device company focused on developing a non-invasive, optical blood glucose monitor. Novoculi's Noninvasive Blood Glucose Monitor aims to build on physiologically demonstrated optical phenomena which forms the basis for Novoculi's technology. Novoculi hopes to leverage its technology to develop a non-invasive blood glucose monitor which will allow its patient population to better manage their blood glucose without a painful finger stick.

A
Advanced BioSensors

Advanced BioSensors is developing a miniaturized blood glucose sensor for use in the treatment of diabetes.

G
Glucose Sensing Technologies

Vytrace Corporation (fka Glucose Sensing Technologies) is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. This is not a consumer product for diabetic glucose monitoring. They also are exploring other analytes that may be monitored with their sensor technology. Vytrace Corporation has a highly accurate bedside monitor that automatically and continuously monitors blood glucose via a fiberoptic catheter with a photonic crystal sensor on the tip.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.